Cargando…

Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Continuous renal replacement therapy (CRRT) is a widely used standard therapy for critically ill patients with acute kidney injury (AKI). Despite its effectiveness, treatment is often interrupted due to clot formation in the extracorporeal circuits. Anticoagulation is a crucial strategy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhifeng, Liu, Chen, Yang, Yingying, Wang, Fang, Zhang, Ling, Fu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249230/ https://www.ncbi.nlm.nih.gov/pubmed/37287084 http://dx.doi.org/10.1186/s13054-023-04519-1

Ejemplares similares

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled trial
por: Wei, Tiantian, et al.
Publicado: (2022)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
por: Klingele, Matthias, et al.
Publicado: (2017)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
por: Liu, Chao, et al.
Publicado: (2016)

Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients
por: Link, Andreas, et al.
Publicado: (2012)

Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19
por: Khadzhynov, Dmytro, et al.
Publicado: (2022)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Reliability of monitoring acid‐base and electrolyte parameters through circuit lines during regional citrate anticoagulation‐continuous renal replacement therapy
por: Wang, Fang, et al.
Publicado: (2021)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Research on the Application Effect of Strengthening Risk Management in Continuous Renal Replacement Therapy Nursing of Critically Ill Patients
por: Yang, Huimei, et al.
Publicado: (2022)

Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy
por: Wu, Lingping, et al.
Publicado: (2017)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
por: Omrani, Ali S., et al.
Publicado: (2015)

Outcome of continuous renal replacement therapy in critically ill children: a retrospective cohort study
por: Al-Ayed, Tareq, et al.
Publicado: (2018)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

Continuous Renal Replacement Therapy (CRRT) for Nonrenal Indications among Critically Ill Children with Malignancy
por: Hui, Wun Fung, et al.
Publicado: (2021)

Continuous Renal Replacement Therapy in the Critically Ill Patient: From Garage Technology to Artificial Intelligence
por: Samoni, Sara, et al.
Publicado: (2021)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
por: Hu, Fang, et al.
Publicado: (2022)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study
por: Arnold, Frederic, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_evod1r9qus8670qm0dk9ccee5s